Switzerland· 69472006

Axitinib Sandoz

A axitinib product containing axitinibum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC L01EK01

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedAxitinib SandozATCL01EK01REGISTER NO.69472006PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Axitinib is registered in 14 of 19 countries.

Countries holding a registration under ATC L01EK01 (axitinib), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 8 of them publish a price we can compare per daily dose

Axitinib · ATC L01EK01

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of axitinib costs, country by country.

Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.

  • Switzerland: $89.71 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Axitinib · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$89.71
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
axitinibum
Manufacturer
—
Country
Switzerland (CH)
ATC code
L01EK01
ATC class
Axitinib
Defined daily dose
10 mg, O
Swissmedic category
A
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680694720069
    Blist 28 Stk
    CHF 1417.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

205 interactions on record for axitinib.

Graded by severity as the source publishes them — 64 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Axitinib · interactions on record

205 records

  • 64 severe
  • 117 moderate
  • 24 minor

Most severe, free to view

  • LonafarnibA16AX20severe
  • BosentanC02KX01severe
  • ConivaptanC03XA02severe
  • MipomersenC10AX11severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Axitinib in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All axitinib products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Axitinib, Axitinib Sandoz
  • Belgium · Axitinib Eg, Axitinib Eg (Eurogenerics)
  • Bulgaria · Axitinib Sandoz, Акситиниб Тева
  • Cyprus · Axitinib Sandoz, Axitinib Stada
  • Germany · Axitinib Al, Axitinib Hexal
  • Denmark · Axitinib Stada, Axitinib Teva
  • Estonia · Axitinib Sandoz, Axitinib Stada
  • Spain · Axitinib Stada, Axitinib Teva
  • Finland · Axitinib Avansor, Axitinib Sandoz
  • France · Axitiinib Eg, Axitinib Biogaran
  • United Kingdom (Northern Ireland) · Axitinib Genus Pharmaceuticals, Axitinib Teva Uk
  • Greece · Axitinib Faran, Axitinib Sandoz
  • Croatia · Aksitinib Alpha-Medical, Aksitinib Teva
  • Hungary · Axitinib Onkogen, Axitinib Sandoz
  • Iceland · Axitinib Accord, Axitinib Stada
  • Italy · Axitinib Eg, Axitinib Sandoz
  • Liechtenstein · Axitinib Accord, Inlyta
  • Lithuania · Axitinib Sandoz, Axitinib Stada
  • Luxembourg · Axitinib Eg, Axitinib Synthon
  • Latvia · Axitinib Sandoz, Axitinib Stada
  • Malta · Axitinib Synthon
  • Netherlands · Axitinib Sandoz, Axitinib Stada
  • Norway · Axitinib Accord, Axitinib Sandoz
  • Portugal · Axitinib Teva
  • Romania · Axitinib Stada
  • Sweden · Axitinib Avansor, Axitinib Sandoz
  • Slovenia · Aksitinib Sandoz, Aksitinib Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e0b1d6d7-4f31-4ada-92df-3317905f33cc
GET /v1/drugs/e0b1d6d7-4f31-4ada-92df-3317905f33cc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "axitinibum 7 mg",
  "valid_from": "2025-07-01",
  "limitations": "[{\"description\":\"Behandlung von Patienten mit fortgeschrittenem Nierenzellkarzinom (RCC) nach Versagen einer vorherigen systemischen Therapie.\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2025-07-01\",\"validTo\":null}]",
  "galenic_form": "Filmtabl 7 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2025-07-01",
  "self_retention_pct": 10
}

See everything about axitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.